fanta.bio Sample: CNhs11745
21274 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1477 / 23585 (6.3%) | 475 / 235850 (0.2%) | −324.0 | −324.0 | 31.09 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 2304 / 23585 (9.8%) | 828 / 235850 (0.4%) | −324.0 | −324.0 | 27.83 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 3200 / 23585 (13.6%) | 1195 / 235850 (0.5%) | −324.0 | −324.0 | 26.78 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 3267 / 23585 (13.9%) | 1235 / 235850 (0.5%) | −324.0 | −324.0 | 26.45 |
| HIF1A SRX11007095 | HK-2 Kidney | 2786 / 23585 (11.8%) | 1090 / 235850 (0.5%) | −324.0 | −324.0 | 25.56 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 2151 / 23585 (9.1%) | 853 / 235850 (0.4%) | −324.0 | −324.0 | 25.22 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 560 / 23585 (2.4%) | 235 / 235850 (0.1%) | −324.0 | −324.0 | 23.83 |
| FOXP1 SRX736067 | LNCAP Prostate | 2697 / 23585 (11.4%) | 1146 / 235850 (0.5%) | −324.0 | −324.0 | 23.53 |
| SCML2 SRX644728 | 293 Kidney | 1927 / 23585 (8.2%) | 826 / 235850 (0.4%) | −324.0 | −324.0 | 23.33 |
| HIF1A SRX20663235 | HK-2 Kidney | 607 / 23585 (2.6%) | 327 / 235850 (0.1%) | −324.0 | −324.0 | 18.56 |
| MYH11 SRX265221 | ME-1 Blood | 1175 / 23585 (5.0%) | 710 / 235850 (0.3%) | −324.0 | −324.0 | 16.55 |
| TP53 SRX19538279 | Osteoblasts Bone | 568 / 23585 (2.4%) | 377 / 235850 (0.2%) | −324.0 | −324.0 | 15.07 |
| MED1 SRX9419945 | BT-474 Breast | 4780 / 23585 (20.3%) | 3297 / 235850 (1.4%) | −324.0 | −324.0 | 14.50 |
| MED1 SRX9419944 | BT-474 Breast | 4648 / 23585 (19.7%) | 3261 / 235850 (1.4%) | −324.0 | −324.0 | 14.25 |
| MED1 SRX9419946 | BT-474 Breast | 4867 / 23585 (20.6%) | 3483 / 235850 (1.5%) | −324.0 | −324.0 | 13.97 |
| BRD4 SRX9419936 | BT-474 Breast | 4854 / 23585 (20.6%) | 3478 / 235850 (1.5%) | −324.0 | −324.0 | 13.96 |
| BRD4 SRX9419935 | BT-474 Breast | 4647 / 23585 (19.7%) | 3347 / 235850 (1.4%) | −324.0 | −324.0 | 13.88 |
| MED1 SRX9419947 | BT-474 Breast | 4725 / 23585 (20.0%) | 3417 / 235850 (1.4%) | −324.0 | −324.0 | 13.83 |
| BRD4 SRX9419938 | BT-474 Breast | 4791 / 23585 (20.3%) | 3488 / 235850 (1.5%) | −324.0 | −324.0 | 13.74 |
| BRD4 SRX9419937 | BT-474 Breast | 4643 / 23585 (19.7%) | 3425 / 235850 (1.5%) | −324.0 | −324.0 | 13.56 |
| EZH2 SRX2146136 | LNCAP Prostate | 11562 / 23585 (49.0%) | 9453 / 235850 (4.0%) | −324.0 | −324.0 | 12.23 |
| BRD4 SRX736201 | 90-8TL Neural | 8244 / 23585 (35.0%) | 8221 / 235850 (3.5%) | −324.0 | −324.0 | 10.03 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 952 / 23585 (4.0%) | 1240 / 235850 (0.5%) | −324.0 | −324.0 | 7.68 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2468 / 23585 (10.5%) | 3358 / 235850 (1.4%) | −324.0 | −324.0 | 7.35 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1698 / 23585 (7.2%) | 5051 / 235850 (2.1%) | −324.0 | −324.0 | 3.36 |
| BRD1 SRX286203 | RKO Digestive tract | 1779 / 23585 (7.5%) | 5468 / 235850 (2.3%) | −324.0 | −324.0 | 3.25 |
| KAT7 SRX101303 | RKO Digestive tract | 2053 / 23585 (8.7%) | 6830 / 235850 (2.9%) | −324.0 | −324.0 | 3.01 |
| Epitope tags SRX10549776 | K-562 Blood | 2076 / 23585 (8.8%) | 7024 / 235850 (3.0%) | −324.0 | −324.0 | 2.96 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 2020 / 23585 (8.6%) | 6974 / 235850 (3.0%) | −324.0 | −324.0 | 2.90 |
| AGO2 SRX4708039 | Hep G2 Liver | 2771 / 23585 (11.7%) | 10057 / 235850 (4.3%) | −324.0 | −324.0 | 2.76 |
| PBX4 SRX2731658 | PC-3 Prostate | 1454 / 23585 (6.2%) | 37437 / 235850 (15.9%) | −324.0 | −324.0 | 0.39 |
| FOS SRX150477 | MCF 10A Breast | 1011 / 23585 (4.3%) | 27854 / 235850 (11.8%) | −324.0 | −324.0 | 0.36 |
| YAP1 SRX757325 | H2052 Lung | 1000 / 23585 (4.2%) | 29093 / 235850 (12.3%) | −324.0 | −324.0 | 0.34 |
| YAP1 SRX757326 | H2052 Lung | 869 / 23585 (3.7%) | 25955 / 235850 (11.0%) | −324.0 | −324.0 | 0.33 |
| FOS SRX150478 | MCF 10A Breast | 1078 / 23585 (4.6%) | 28504 / 235850 (12.1%) | −322.8 | −319.9 | 0.38 |
| AGO2 SRX6783958 | Hep G2 Liver | 1801 / 23585 (7.6%) | 5921 / 235850 (2.5%) | −313.6 | −310.7 | 3.04 |
| BRPF3 SRX796086 | RKO Digestive tract | 2127 / 23585 (9.0%) | 7844 / 235850 (3.3%) | −312.9 | −310.0 | 2.71 |
| BRPF3 SRX796084 | RKO Digestive tract | 2193 / 23585 (9.3%) | 8293 / 235850 (3.5%) | −309.9 | −306.9 | 2.64 |
| SS18 SRX3468047 | Fibroblasts Others | 1110 / 23585 (4.7%) | 28474 / 235850 (12.1%) | −308.4 | −305.5 | 0.39 |
| ESR1 SRX7624157 | MCF-7 Breast | 1156 / 23585 (4.9%) | 29106 / 235850 (12.3%) | −307.2 | −304.3 | 0.40 |
| TP53 SRX19538268 | U2OS Bone | 469 / 23585 (2.0%) | 236 / 235850 (0.1%) | −306.1 | −303.2 | 19.87 |
| TP53 SRX19538274 | U2OS Bone | 469 / 23585 (2.0%) | 237 / 235850 (0.1%) | −305.7 | −302.8 | 19.79 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 808 / 23585 (3.4%) | 1224 / 235850 (0.5%) | −304.7 | −301.8 | 6.60 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 694 / 23585 (2.9%) | 849 / 235850 (0.4%) | −301.5 | −298.7 | 8.17 |
| AGO2 SRX6783957 | Hep G2 Liver | 1796 / 23585 (7.6%) | 6078 / 235850 (2.6%) | −299.9 | −297.0 | 2.95 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1549 / 23585 (6.6%) | 34303 / 235850 (14.5%) | −296.5 | −293.7 | 0.45 |
| GATA3 SRX190194 | SK-N-SH Neural | 1060 / 23585 (4.5%) | 27262 / 235850 (11.6%) | −295.2 | −292.4 | 0.39 |
| ESR1 SRX4367193 | MCF-7 Breast | 1495 / 23585 (6.3%) | 33464 / 235850 (14.2%) | −294.2 | −291.4 | 0.45 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 1064 / 23585 (4.5%) | 27215 / 235850 (11.5%) | −292.2 | −289.4 | 0.39 |
| FOXA1 SRX4815197 | MCF-7 Breast | 1124 / 23585 (4.8%) | 28078 / 235850 (11.9%) | −291.7 | −288.9 | 0.40 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 1108 / 23585 (4.7%) | 27785 / 235850 (11.8%) | −290.1 | −287.3 | 0.40 |
| Epitope tags DRX443510 | 293 Kidney | 2132 / 23585 (9.0%) | 8294 / 235850 (3.5%) | −286.6 | −283.8 | 2.57 |
| TP53 SRX19538276 | U2OS Bone | 456 / 23585 (1.9%) | 256 / 235850 (0.1%) | −286.5 | −283.7 | 17.81 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 1102 / 23585 (4.7%) | 27569 / 235850 (11.7%) | −286.5 | −283.7 | 0.40 |
| MEAF6 DRX234811 | 293 Kidney | 2421 / 23585 (10.3%) | 10163 / 235850 (4.3%) | −285.1 | −282.4 | 2.38 |
| ESR1 SRX371478 | MCF-7 Breast | 589 / 23585 (2.5%) | 19435 / 235850 (8.2%) | −281.5 | −278.8 | 0.30 |
| BRPF3 SRX796085 | RKO Digestive tract | 1531 / 23585 (6.5%) | 4830 / 235850 (2.0%) | −281.0 | −278.3 | 3.17 |
| FOXA1 SRX176863 | MCF-7 Breast | 555 / 23585 (2.4%) | 18819 / 235850 (8.0%) | −280.0 | −277.3 | 0.29 |
| MEAF6 DRX300417 | 293 Kidney | 2225 / 23585 (9.4%) | 8992 / 235850 (3.8%) | −280.0 | −277.2 | 2.47 |
| FOXA1 SRX176862 | MCF-7 Breast | 612 / 23585 (2.6%) | 19733 / 235850 (8.4%) | −279.1 | −276.3 | 0.31 |
| FOS SRX4192880 | MCF 10A Breast | 795 / 23585 (3.4%) | 22601 / 235850 (9.6%) | −277.2 | −274.4 | 0.35 |
| TP53 SRX19538267 | U2OS Bone | 421 / 23585 (1.8%) | 208 / 235850 (0.1%) | −276.5 | −273.7 | 20.24 |
| ESR1 SRX20282961 | MCF-7 Breast | 594 / 23585 (2.5%) | 19255 / 235850 (8.2%) | −273.5 | −270.8 | 0.31 |
| ESR1 SRX176861 | MCF-7 Breast | 780 / 23585 (3.3%) | 22231 / 235850 (9.4%) | −273.2 | −270.5 | 0.35 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 911 / 23585 (3.9%) | 24218 / 235850 (10.3%) | −272.5 | −269.8 | 0.38 |
| ESR1 SRX7624156 | MCF-7 Breast | 759 / 23585 (3.2%) | 21840 / 235850 (9.3%) | −271.4 | −268.7 | 0.35 |
| ESR1 SRX371469 | MCF-7 Breast | 483 / 23585 (2.0%) | 17306 / 235850 (7.3%) | −271.1 | −268.4 | 0.28 |
| ING5 SRX286202 | RKO Digestive tract | 1881 / 23585 (8.0%) | 7008 / 235850 (3.0%) | −270.6 | −267.9 | 2.68 |
| ESR1 SRX176860 | MCF-7 Breast | 783 / 23585 (3.3%) | 22190 / 235850 (9.4%) | −270.6 | −267.9 | 0.35 |
| MAU2 SRX15710550 | Fibroblasts Others | 762 / 23585 (3.2%) | 21845 / 235850 (9.3%) | −270.1 | −267.4 | 0.35 |
| TP53 SRX19538280 | Osteoblasts Bone | 449 / 23585 (1.9%) | 285 / 235850 (0.1%) | −269.4 | −266.8 | 15.75 |
| TCF12 SRX190356 | SK-N-SH Neural | 1301 / 23585 (5.5%) | 29779 / 235850 (12.6%) | −269.0 | −266.3 | 0.44 |
| AR SRX1067071 | LHSAR Prostate | 946 / 23585 (4.0%) | 24508 / 235850 (10.4%) | −265.8 | −263.1 | 0.39 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1634 / 23585 (6.9%) | 34244 / 235850 (14.5%) | −265.6 | −262.9 | 0.48 |
| NR3C1 SRX2609664 | HASM2 Lung | 648 / 23585 (2.7%) | 19868 / 235850 (8.4%) | −265.3 | −262.7 | 0.33 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 665 / 23585 (2.8%) | 930 / 235850 (0.4%) | −264.9 | −262.2 | 7.15 |
| AR SRX10820653 | LNCAP Prostate | 424 / 23585 (1.8%) | 254 / 235850 (0.1%) | −260.1 | −257.5 | 16.69 |
| TP53 SRX19538273 | U2OS Bone | 405 / 23585 (1.7%) | 214 / 235850 (0.1%) | −260.0 | −257.4 | 18.93 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 338 / 23585 (1.4%) | 14368 / 235850 (6.1%) | −259.7 | −257.1 | 0.24 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 1215 / 23585 (5.2%) | 28100 / 235850 (11.9%) | −257.0 | −254.4 | 0.43 |
| FOS SRX150517 | MCF 10A Breast | 842 / 23585 (3.6%) | 22620 / 235850 (9.6%) | −256.9 | −254.3 | 0.37 |
| TP53 SRX19538275 | U2OS Bone | 414 / 23585 (1.8%) | 242 / 235850 (0.1%) | −256.3 | −253.7 | 17.11 |
| FOXA1 SRX1161177 | MCF-7 Breast | 494 / 23585 (2.1%) | 17007 / 235850 (7.2%) | −255.8 | −253.2 | 0.29 |
| JUN SRX6582171 | GM07492 Others | 943 / 23585 (4.0%) | 24089 / 235850 (10.2%) | −255.5 | −252.9 | 0.39 |
| FOXA1 SRX371481 | MCF-7 Breast | 523 / 23585 (2.2%) | 17466 / 235850 (7.4%) | −254.8 | −252.2 | 0.30 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1774 / 23585 (7.5%) | 35666 / 235850 (15.1%) | −254.5 | −252.0 | 0.50 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1650 / 23585 (7.0%) | 33993 / 235850 (14.4%) | −254.2 | −251.7 | 0.49 |
| ESR1 SRX371476 | MCF-7 Breast | 350 / 23585 (1.5%) | 14410 / 235850 (6.1%) | −253.7 | −251.1 | 0.24 |
| TP53 SRX19538281 | Osteoblasts Bone | 480 / 23585 (2.0%) | 411 / 235850 (0.2%) | −253.0 | −250.4 | 11.68 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 739 / 23585 (3.1%) | 1274 / 235850 (0.5%) | −252.4 | −249.9 | 5.80 |
| ESR1 SRX20282939 | MCF-7 Breast | 565 / 23585 (2.4%) | 18084 / 235850 (7.7%) | −252.3 | −249.7 | 0.31 |
| ESR1 SRX1531791 | MCF-7 Breast | 467 / 23585 (2.0%) | 16424 / 235850 (7.0%) | −251.9 | −249.3 | 0.28 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 583 / 23585 (2.5%) | 18329 / 235850 (7.8%) | −250.9 | −248.3 | 0.32 |
| FOXA1 SRX371483 | MCF-7 Breast | 570 / 23585 (2.4%) | 18101 / 235850 (7.7%) | −250.4 | −247.8 | 0.31 |
| ESR1 SRX20282960 | MCF-7 Breast | 571 / 23585 (2.4%) | 18111 / 235850 (7.7%) | −250.2 | −247.7 | 0.32 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 583 / 23585 (2.5%) | 18222 / 235850 (7.7%) | −247.6 | −245.1 | 0.32 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 715 / 23585 (3.0%) | 20325 / 235850 (8.6%) | −247.5 | −244.9 | 0.35 |
| SMARCA2 SRX8119677 | MeT-5A Others | 807 / 23585 (3.4%) | 21736 / 235850 (9.2%) | −247.1 | −244.6 | 0.37 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 370 / 23585 (1.6%) | 14553 / 235850 (6.2%) | −246.6 | −244.0 | 0.25 |
| NR3C1 SRX2609665 | HASM2 Lung | 529 / 23585 (2.2%) | 17295 / 235850 (7.3%) | −246.5 | −244.0 | 0.31 |
| JUNB SRX8488073 | SUM 229PE Breast | 935 / 23585 (4.0%) | 23615 / 235850 (10.0%) | −245.8 | −243.3 | 0.40 |
| AR SRX1067070 | LHSAR Prostate | 1236 / 23585 (5.2%) | 27911 / 235850 (11.8%) | −244.4 | −241.9 | 0.44 |
| FOXA1 SRX3931044 | MCF-7 Breast | 1102 / 23585 (4.7%) | 25975 / 235850 (11.0%) | −243.7 | −241.2 | 0.42 |
| ESR1 SRX371479 | MCF-7 Breast | 467 / 23585 (2.0%) | 16140 / 235850 (6.8%) | −243.0 | −240.5 | 0.29 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1943 / 23585 (8.2%) | 37352 / 235850 (15.8%) | −242.0 | −239.5 | 0.52 |
| FOXA1 SRX371482 | MCF-7 Breast | 749 / 23585 (3.2%) | 20661 / 235850 (8.8%) | −241.9 | −239.4 | 0.36 |
| YAP1 SRX5718140 | 293 Kidney | 864 / 23585 (3.7%) | 22397 / 235850 (9.5%) | −241.6 | −239.1 | 0.39 |
| ESR1 SRX371467 | MCF-7 Breast | 533 / 23585 (2.3%) | 17140 / 235850 (7.3%) | −239.7 | −237.2 | 0.31 |
| NR3C1 SRX2609659 | HASM2 Lung | 574 / 23585 (2.4%) | 17799 / 235850 (7.5%) | −239.3 | −236.8 | 0.32 |
| NR3C1 SRX2609662 | HASM2 Lung | 589 / 23585 (2.5%) | 18037 / 235850 (7.6%) | −239.1 | −236.7 | 0.33 |
| FOXA1 SRX1161173 | MCF-7 Breast | 402 / 23585 (1.7%) | 14847 / 235850 (6.3%) | −237.8 | −235.3 | 0.27 |
| EP300 SRX2671813 | Fibroblasts Others | 399 / 23585 (1.7%) | 14776 / 235850 (6.3%) | −237.2 | −234.7 | 0.27 |
| FOXA1 SRX1161176 | MCF-7 Breast | 494 / 23585 (2.1%) | 16398 / 235850 (7.0%) | −236.9 | −234.5 | 0.30 |
| GATA3 SRX190239 | MCF-7 Breast | 765 / 23585 (3.2%) | 20719 / 235850 (8.8%) | −236.7 | −234.2 | 0.37 |
| JUN SRX17561461 | LPS141 Adipocyte | 742 / 23585 (3.1%) | 20330 / 235850 (8.6%) | −235.7 | −233.2 | 0.36 |
| ESR1 SRX10365536 | MCF-7 Breast | 249 / 23585 (1.1%) | 11954 / 235850 (5.1%) | −235.2 | −232.8 | 0.21 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1632 / 23585 (6.9%) | 32936 / 235850 (14.0%) | −234.6 | −232.2 | 0.50 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 887 / 23585 (3.8%) | 22482 / 235850 (9.5%) | −234.5 | −232.1 | 0.39 |
| ESR1 SRX20282954 | MCF-7 Breast | 565 / 23585 (2.4%) | 17485 / 235850 (7.4%) | −234.4 | −232.0 | 0.32 |
| NR3C1 SRX2609661 | HASM2 Lung | 551 / 23585 (2.3%) | 17236 / 235850 (7.3%) | −233.8 | −231.3 | 0.32 |
| ESR1 SRX194569 | MCF-7 Breast | 542 / 23585 (2.3%) | 17077 / 235850 (7.2%) | −233.3 | −230.9 | 0.32 |
| JADE3 DRX300415 | 293 Kidney | 2095 / 23585 (8.9%) | 9020 / 235850 (3.8%) | −232.9 | −230.4 | 2.32 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 1095 / 23585 (4.6%) | 25433 / 235850 (10.8%) | −232.3 | −229.8 | 0.43 |
| ESR1 SRX20282972 | MCF-7 Breast | 583 / 23585 (2.5%) | 17695 / 235850 (7.5%) | −232.0 | −229.6 | 0.33 |
| TLE3 SRX4815191 | MCF-7 Breast | 511 / 23585 (2.2%) | 16468 / 235850 (7.0%) | −230.4 | −228.0 | 0.31 |
| NR3C1 SRX2609666 | HASM2 Lung | 478 / 23585 (2.0%) | 15901 / 235850 (6.7%) | −229.9 | −227.5 | 0.30 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 1165 / 23585 (4.9%) | 26325 / 235850 (11.2%) | −229.6 | −227.2 | 0.44 |
| EP300 SRX2194266 | SUM 159PT Breast | 889 / 23585 (3.8%) | 22330 / 235850 (9.5%) | −229.5 | −227.1 | 0.40 |
| FOXA1 SRX1161175 | MCF-7 Breast | 390 / 23585 (1.7%) | 14340 / 235850 (6.1%) | −228.4 | −225.9 | 0.27 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 511 / 23585 (2.2%) | 16384 / 235850 (6.9%) | −227.9 | −225.5 | 0.31 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 771 / 23585 (3.3%) | 20470 / 235850 (8.7%) | −227.2 | −224.8 | 0.38 |
| ESR1 SRX371471 | ZR-75-1 Breast | 581 / 23585 (2.5%) | 17466 / 235850 (7.4%) | −226.2 | −223.8 | 0.33 |
| TP53 SRX396254 | Fibroblasts Others | 1190 / 23585 (5.0%) | 3648 / 235850 (1.5%) | −225.7 | −223.3 | 3.26 |
| ESR1 SRX371468 | MCF-7 Breast | 332 / 23585 (1.4%) | 13218 / 235850 (5.6%) | −225.4 | −223.1 | 0.25 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 779 / 23585 (3.3%) | 20513 / 235850 (8.7%) | −225.0 | −222.6 | 0.38 |
| ESR1 SRX4367192 | MCF-7 Breast | 1071 / 23585 (4.5%) | 24807 / 235850 (10.5%) | −225.0 | −222.6 | 0.43 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 779 / 23585 (3.3%) | 20485 / 235850 (8.7%) | −224.2 | −221.8 | 0.38 |
| GATA3 SRX176864 | MCF-7 Breast | 384 / 23585 (1.6%) | 14099 / 235850 (6.0%) | −224.1 | −221.7 | 0.27 |
| FOS SRX150476 | MCF 10A Breast | 924 / 23585 (3.9%) | 22636 / 235850 (9.6%) | −223.9 | −221.6 | 0.41 |
| RAC1 SRX10365541 | MCF-7 Breast | 268 / 23585 (1.1%) | 11979 / 235850 (5.1%) | −223.7 | −221.4 | 0.22 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 1212 / 23585 (5.1%) | 3792 / 235850 (1.6%) | −223.7 | −221.3 | 3.20 |
| JUNB SRX8488088 | SUM 229PE Breast | 1031 / 23585 (4.4%) | 24154 / 235850 (10.2%) | −222.9 | −220.5 | 0.43 |
| ESR1 SRX10365535 | MCF-7 Breast | 422 / 23585 (1.8%) | 14694 / 235850 (6.2%) | −222.1 | −219.7 | 0.29 |
| ESR1 SRX194572 | MCF-7 Breast | 333 / 23585 (1.4%) | 13128 / 235850 (5.6%) | −222.0 | −219.6 | 0.25 |
| RAC1 SRX10365543 | MCF-7 Breast | 270 / 23585 (1.1%) | 11948 / 235850 (5.1%) | −221.4 | −219.1 | 0.23 |
| KAT7 DRX234808 | 293 Kidney | 1064 / 23585 (4.5%) | 3030 / 235850 (1.3%) | −221.4 | −219.1 | 3.51 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 691 / 23585 (2.9%) | 19012 / 235850 (8.1%) | −220.8 | −218.4 | 0.36 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 689 / 23585 (2.9%) | 18974 / 235850 (8.0%) | −220.6 | −218.3 | 0.36 |
| ESR1 SRX371470 | ZR-75-1 Breast | 494 / 23585 (2.1%) | 15857 / 235850 (6.7%) | −220.5 | −218.1 | 0.31 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 528 / 23585 (2.2%) | 16406 / 235850 (7.0%) | −220.3 | −218.0 | 0.32 |
| JADE3 DRX234809 | 293 Kidney | 1399 / 23585 (5.9%) | 4897 / 235850 (2.1%) | −220.2 | −217.8 | 2.86 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1557 / 23585 (6.6%) | 31307 / 235850 (13.3%) | −219.9 | −217.6 | 0.50 |
| TP53 SRX19538269 | U2OS Bone | 500 / 23585 (2.1%) | 599 / 235850 (0.3%) | −219.8 | −217.5 | 8.35 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 679 / 23585 (2.9%) | 1251 / 235850 (0.5%) | −219.5 | −217.2 | 5.43 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 815 / 23585 (3.5%) | 1837 / 235850 (0.8%) | −219.3 | −216.9 | 4.44 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1518 / 23585 (6.4%) | 30683 / 235850 (13.0%) | −217.6 | −215.2 | 0.49 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 501 / 23585 (2.1%) | 15872 / 235850 (6.7%) | −217.6 | −215.2 | 0.32 |
| FOS SRX4192879 | MCF 10A Breast | 624 / 23585 (2.6%) | 17848 / 235850 (7.6%) | −217.4 | −215.0 | 0.35 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 488 / 23585 (2.1%) | 15630 / 235850 (6.6%) | −216.7 | −214.4 | 0.31 |
| ESR1 SRX2881000 | MCF-7 Breast | 462 / 23585 (2.0%) | 15173 / 235850 (6.4%) | −216.0 | −213.7 | 0.30 |
| SMARCA4 SRX5212362 | Mel270 Others | 924 / 23585 (3.9%) | 22323 / 235850 (9.5%) | −215.7 | −213.4 | 0.41 |
| GATA3 SRX5057632 | MCF-7 Breast | 349 / 23585 (1.5%) | 13213 / 235850 (5.6%) | −215.6 | −213.3 | 0.26 |
| ESR1 SRX2881002 | MCF-7 Breast | 502 / 23585 (2.1%) | 15808 / 235850 (6.7%) | −215.2 | −212.9 | 0.32 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 501 / 23585 (2.1%) | 15779 / 235850 (6.7%) | −214.8 | −212.5 | 0.32 |
| LEO1 SRX1873456 | SEM Blood | 1935 / 23585 (8.2%) | 8330 / 235850 (3.5%) | −214.3 | −212.0 | 2.32 |
| ESR1 SRX371477 | MCF-7 Breast | 258 / 23585 (1.1%) | 11506 / 235850 (4.9%) | −214.3 | −212.0 | 0.22 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 827 / 23585 (3.5%) | 1936 / 235850 (0.8%) | −214.1 | −211.8 | 4.27 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1540 / 23585 (6.5%) | 30824 / 235850 (13.1%) | −214.0 | −211.7 | 0.50 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 586 / 23585 (2.5%) | 17125 / 235850 (7.3%) | −214.0 | −211.7 | 0.34 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 317 / 23585 (1.3%) | 144 / 235850 (0.1%) | −213.9 | −211.6 | 22.01 |
| JUNB SRX8488074 | SUM 229PE Breast | 717 / 23585 (3.0%) | 19134 / 235850 (8.1%) | −213.0 | −210.7 | 0.37 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 2057 / 23585 (8.7%) | 9168 / 235850 (3.9%) | −212.9 | −210.6 | 2.24 |
| FOXA1 SRX371480 | MCF-7 Breast | 375 / 23585 (1.6%) | 13588 / 235850 (5.8%) | −212.9 | −210.6 | 0.28 |
| FOXA1 SRX100454 | T-47D Breast | 713 / 23585 (3.0%) | 19057 / 235850 (8.1%) | −212.6 | −210.3 | 0.37 |
| ESR1 SRX20282973 | MCF-7 Breast | 662 / 23585 (2.8%) | 18257 / 235850 (7.7%) | −212.2 | −209.9 | 0.36 |
| ESR1 SRX20282955 | MCF-7 Breast | 579 / 23585 (2.5%) | 16944 / 235850 (7.2%) | −212.0 | −209.7 | 0.34 |
| PBX3 SRX190343 | SK-N-SH Neural | 1121 / 23585 (4.8%) | 24997 / 235850 (10.6%) | −211.8 | −209.5 | 0.45 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 1033 / 23585 (4.4%) | 23737 / 235850 (10.1%) | −211.5 | −209.3 | 0.44 |
| SMARCA4 SRX5212366 | Mel270 Others | 731 / 23585 (3.1%) | 19273 / 235850 (8.2%) | −210.9 | −208.7 | 0.38 |
| TP53 SRX19538270 | U2OS Bone | 483 / 23585 (2.0%) | 589 / 235850 (0.2%) | −210.0 | −207.8 | 8.20 |
| PRRX1 SRX15235713 | Hs 578T Breast | 660 / 23585 (2.8%) | 18147 / 235850 (7.7%) | −209.9 | −207.7 | 0.36 |
| AR SRX10820651 | LNCAP Prostate | 428 / 23585 (1.8%) | 430 / 235850 (0.2%) | −208.0 | −205.7 | 9.95 |
| FOXA1 SRX11222437 | MCF-7 Breast | 392 / 23585 (1.7%) | 13716 / 235850 (5.8%) | −207.7 | −205.4 | 0.29 |
| ESR1 SRX10365532 | MCF-7 Breast | 288 / 23585 (1.2%) | 11863 / 235850 (5.0%) | −207.5 | −205.3 | 0.24 |
| FOXA1 SRX1161174 | MCF-7 Breast | 577 / 23585 (2.4%) | 16747 / 235850 (7.1%) | −207.2 | −205.0 | 0.34 |
| FOXA1 SRX11222441 | MCF-7 Breast | 421 / 23585 (1.8%) | 14184 / 235850 (6.0%) | −206.8 | −204.6 | 0.30 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1423 / 23585 (6.0%) | 28943 / 235850 (12.3%) | −206.8 | −204.5 | 0.49 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 1082 / 23585 (4.6%) | 3295 / 235850 (1.4%) | −206.7 | −204.4 | 3.28 |
| ESR1 SRX3110725 | MCF-7 Breast | 488 / 23585 (2.1%) | 15288 / 235850 (6.5%) | −206.5 | −204.3 | 0.32 |
| STAT1 SRX23678708 | K-562 Blood | 2039 / 23585 (8.6%) | 9189 / 235850 (3.9%) | −206.1 | −203.8 | 2.22 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 443 / 23585 (1.9%) | 14498 / 235850 (6.1%) | −205.3 | −203.0 | 0.31 |
| Epitope tags SRX10549778 | K-562 Blood | 1481 / 23585 (6.3%) | 5616 / 235850 (2.4%) | −205.1 | −202.9 | 2.64 |
| SSRP1 SRX3436567 | HT-1080 Bone | 518 / 23585 (2.2%) | 730 / 235850 (0.3%) | −205.1 | −202.8 | 7.10 |
| JUN SRX6582172 | Fibroblasts Others | 731 / 23585 (3.1%) | 19058 / 235850 (8.1%) | −205.1 | −202.8 | 0.38 |
| IRF3 SRX11453858 | Hep G2 Liver | 297 / 23585 (1.3%) | 126 / 235850 (0.1%) | −204.7 | −202.4 | 23.57 |
| SMARCA4 SRX5212371 | Mel270 Others | 781 / 23585 (3.3%) | 19786 / 235850 (8.4%) | −204.4 | −202.2 | 0.39 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 914 / 23585 (3.9%) | 21746 / 235850 (9.2%) | −204.4 | −202.2 | 0.42 |
| FOXA1 SRX3923514 | MCF-7 Breast | 573 / 23585 (2.4%) | 16559 / 235850 (7.0%) | −203.6 | −201.4 | 0.35 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 397 / 23585 (1.7%) | 13654 / 235850 (5.8%) | −203.2 | −201.0 | 0.29 |
| FOXA1 SRX1787653 | MCF-7 Breast | 463 / 23585 (2.0%) | 14766 / 235850 (6.3%) | −203.2 | −201.0 | 0.31 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 972 / 23585 (4.1%) | 22525 / 235850 (9.6%) | −202.9 | −200.7 | 0.43 |
| EP300 SRX100540 | SK-N-SH Neural | 801 / 23585 (3.4%) | 20021 / 235850 (8.5%) | −202.7 | −200.5 | 0.40 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 559 / 23585 (2.4%) | 16299 / 235850 (6.9%) | −202.6 | −200.4 | 0.34 |
| ESR1 SRX20282946 | MCF-7 Breast | 330 / 23585 (1.4%) | 12468 / 235850 (5.3%) | −202.6 | −200.4 | 0.26 |
| SMARCA4 SRX5212357 | Mel270 Others | 806 / 23585 (3.4%) | 20060 / 235850 (8.5%) | −201.8 | −199.6 | 0.40 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 1212 / 23585 (5.1%) | 25840 / 235850 (11.0%) | −201.5 | −199.3 | 0.47 |
| BRD4 SRX736204 | 90-8TL Neural | 1190 / 23585 (5.0%) | 3960 / 235850 (1.7%) | −201.2 | −199.0 | 3.01 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 966 / 23585 (4.1%) | 22370 / 235850 (9.5%) | −201.1 | −198.9 | 0.43 |
| JUN SRX6582163 | BJ-5ta Epidermis | 700 / 23585 (3.0%) | 18420 / 235850 (7.8%) | −200.5 | −198.3 | 0.38 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 1251 / 23585 (5.3%) | 26338 / 235850 (11.2%) | −200.5 | −198.3 | 0.47 |
| EP300 ERX626811 | U-937 Blood | 1627 / 23585 (6.9%) | 6608 / 235850 (2.8%) | −200.2 | −198.0 | 2.46 |
| ESR1 SRX20282940 | MCF-7 Breast | 620 / 23585 (2.6%) | 17174 / 235850 (7.3%) | −200.1 | −197.9 | 0.36 |
| EP300 ERX626821 | U-937 Blood | 1625 / 23585 (6.9%) | 6614 / 235850 (2.8%) | −199.0 | −196.8 | 2.46 |
| ESR1 SRX371475 | BT-474 Breast | 282 / 23585 (1.2%) | 11476 / 235850 (4.9%) | −198.6 | −196.4 | 0.25 |
| JUND SRX190357 | SK-N-SH Neural | 710 / 23585 (3.0%) | 18495 / 235850 (7.8%) | −198.5 | −196.3 | 0.38 |
| JUNB SRX10119386 | MCF 10A Breast | 516 / 23585 (2.2%) | 15467 / 235850 (6.6%) | −198.4 | −196.2 | 0.33 |
| ARID1A SRX5089376 | MCF-7 Breast | 502 / 23585 (2.1%) | 15198 / 235850 (6.4%) | −197.2 | −195.0 | 0.33 |
| BMI1 SRX644729 | 293 Kidney | 307 / 23585 (1.3%) | 162 / 235850 (0.1%) | −197.2 | −195.0 | 18.95 |
| FOXA1 SRX11222442 | MCF-7 Breast | 379 / 23585 (1.6%) | 13139 / 235850 (5.6%) | −196.9 | −194.7 | 0.29 |
| ESR1 SRX330069 | MCF-7 Breast | 343 / 23585 (1.5%) | 12495 / 235850 (5.3%) | −196.3 | −194.1 | 0.27 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 970 / 23585 (4.1%) | 22234 / 235850 (9.4%) | −196.2 | −194.1 | 0.44 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 1033 / 23585 (4.4%) | 3159 / 235850 (1.3%) | −196.1 | −193.9 | 3.27 |
| Epitope tags SRX5877912 | U2OS Bone | 3053 / 23585 (12.9%) | 48929 / 235850 (20.7%) | −195.9 | −193.7 | 0.62 |
| FOXA1 SRX5323843 | MCF-7 Breast | 290 / 23585 (1.2%) | 11537 / 235850 (4.9%) | −195.8 | −193.7 | 0.25 |
| ESR1 SRX371474 | BT-474 Breast | 255 / 23585 (1.1%) | 10893 / 235850 (4.6%) | −195.8 | −193.6 | 0.23 |
| TLE3 SRX4815192 | MCF-7 Breast | 522 / 23585 (2.2%) | 15472 / 235850 (6.6%) | −195.8 | −193.6 | 0.34 |
| FOSL2 SRX190296 | SK-N-SH Neural | 757 / 23585 (3.2%) | 19100 / 235850 (8.1%) | −195.7 | −193.5 | 0.40 |
| TCF21 DRX190655 | HCF Cardiovascular | 938 / 23585 (4.0%) | 21749 / 235850 (9.2%) | −195.7 | −193.5 | 0.43 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 496 / 23585 (2.1%) | 15044 / 235850 (6.4%) | −195.5 | −193.4 | 0.33 |
| ESR1 SRX2943591 | MCF-7 Breast | 404 / 23585 (1.7%) | 13511 / 235850 (5.7%) | −195.2 | −193.1 | 0.30 |
| 5-mC SRX882970 | LNCAP Prostate | 3630 / 23585 (15.4%) | 21177 / 235850 (9.0%) | −195.1 | −193.0 | 1.71 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 720 / 23585 (3.1%) | 18503 / 235850 (7.8%) | −194.6 | −192.4 | 0.39 |
| EP300 SRX2194265 | SUM 159PT Breast | 888 / 23585 (3.8%) | 20978 / 235850 (8.9%) | −194.4 | −192.3 | 0.42 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 275 / 23585 (1.2%) | 11218 / 235850 (4.8%) | −194.3 | −192.2 | 0.25 |
| ESR1 SRX330070 | MCF-7 Breast | 287 / 23585 (1.2%) | 11430 / 235850 (4.8%) | −194.1 | −192.0 | 0.25 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 999 / 23585 (4.2%) | 3007 / 235850 (1.3%) | −193.5 | −191.4 | 3.32 |
| ESR1 SRX8537722 | MCF-7 Breast | 530 / 23585 (2.2%) | 15509 / 235850 (6.6%) | −193.2 | −191.0 | 0.34 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 1101 / 23585 (4.7%) | 23941 / 235850 (10.2%) | −192.7 | −190.6 | 0.46 |
| TP53 SRX19538282 | Osteoblasts Bone | 408 / 23585 (1.7%) | 432 / 235850 (0.2%) | −192.7 | −190.5 | 9.44 |
| ESR1 SRX330067 | MCF-7 Breast | 525 / 23585 (2.2%) | 15391 / 235850 (6.5%) | −192.1 | −190.0 | 0.34 |
| ESR1 SRX10365558 | MCF-7 Breast | 386 / 23585 (1.6%) | 13101 / 235850 (5.6%) | −192.0 | −189.8 | 0.29 |
| AR SRX9469988 | LAPC-4 Prostate | 771 / 23585 (3.3%) | 19150 / 235850 (8.1%) | −191.5 | −189.4 | 0.40 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 1031 / 23585 (4.4%) | 22901 / 235850 (9.7%) | −191.3 | −189.2 | 0.45 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 527 / 23585 (2.2%) | 15386 / 235850 (6.5%) | −191.0 | −188.9 | 0.34 |
| ESR1 SRX20282953 | MCF-7 Breast | 476 / 23585 (2.0%) | 14559 / 235850 (6.2%) | −190.9 | −188.7 | 0.33 |
| Epitope tags SRX15939724 | RD Muscle | 497 / 23585 (2.1%) | 14894 / 235850 (6.3%) | −190.7 | −188.6 | 0.33 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 1134 / 23585 (4.8%) | 3790 / 235850 (1.6%) | −190.2 | −188.1 | 2.99 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 558 / 23585 (2.4%) | 15835 / 235850 (6.7%) | −189.8 | −187.7 | 0.35 |
| STAT1 SRX23678707 | K-562 Blood | 1872 / 23585 (7.9%) | 8410 / 235850 (3.6%) | −189.7 | −187.6 | 2.23 |
| FOXA1 SRX028634 | MCF-7 Breast | 289 / 23585 (1.2%) | 11326 / 235850 (4.8%) | −189.6 | −187.4 | 0.26 |
| FOXL2 SRX6957431 | KGN Gonad | 1301 / 23585 (5.5%) | 26547 / 235850 (11.3%) | −189.4 | −187.3 | 0.49 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 604 / 23585 (2.6%) | 16539 / 235850 (7.0%) | −189.4 | −187.2 | 0.37 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1742 / 23585 (7.4%) | 7577 / 235850 (3.2%) | −188.2 | −186.0 | 2.30 |
| ESR1 SRX20282971 | MCF-7 Breast | 583 / 23585 (2.5%) | 16166 / 235850 (6.9%) | −188.1 | −186.0 | 0.36 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 1124 / 23585 (4.8%) | 24008 / 235850 (10.2%) | −186.6 | −184.5 | 0.47 |
| ESR1 SRX10365533 | MCF-7 Breast | 276 / 23585 (1.2%) | 10989 / 235850 (4.7%) | −186.4 | −184.3 | 0.25 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1831 / 23585 (7.8%) | 8204 / 235850 (3.5%) | −186.4 | −184.3 | 2.23 |
| WWTR1 SRX10119367 | MCF 10A Breast | 687 / 23585 (2.9%) | 17691 / 235850 (7.5%) | −186.2 | −184.1 | 0.39 |
| FOXA1 SRX1787651 | MCF-7 Breast | 335 / 23585 (1.4%) | 12032 / 235850 (5.1%) | −186.1 | −184.0 | 0.28 |
| ESR1 SRX20282938 | MCF-7 Breast | 477 / 23585 (2.0%) | 14405 / 235850 (6.1%) | −186.0 | −183.9 | 0.33 |
| KAT7 DRX300414 | 293 Kidney | 803 / 23585 (3.4%) | 2085 / 235850 (0.9%) | −185.8 | −183.7 | 3.85 |
| 5-mC SRX882968 | LNCAP Prostate | 3567 / 23585 (15.1%) | 20998 / 235850 (8.9%) | −185.7 | −183.6 | 1.70 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 502 / 23585 (2.1%) | 14802 / 235850 (6.3%) | −185.7 | −183.6 | 0.34 |
| CEBPB SRX150632 | HeLa Uterus | 1289 / 23585 (5.5%) | 26222 / 235850 (11.1%) | −185.6 | −183.5 | 0.49 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 993 / 23585 (4.2%) | 22129 / 235850 (9.4%) | −185.5 | −183.4 | 0.45 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 826 / 23585 (3.5%) | 19725 / 235850 (8.4%) | −185.4 | −183.3 | 0.42 |
| JUN SRX4192884 | MCF 10A Breast | 500 / 23585 (2.1%) | 14715 / 235850 (6.2%) | −184.2 | −182.1 | 0.34 |
| VGLL1 SRX24602130 | BT-20 Breast | 630 / 23585 (2.7%) | 16730 / 235850 (7.1%) | −183.7 | −181.6 | 0.38 |
| ESR1 SRX1469949 | MCF-7 Breast | 338 / 23585 (1.4%) | 11999 / 235850 (5.1%) | −183.6 | −181.5 | 0.28 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 794 / 23585 (3.4%) | 19171 / 235850 (8.1%) | −183.2 | −181.1 | 0.41 |
| ESR1 SRX1012629 | MCF-7 Breast | 374 / 23585 (1.6%) | 12602 / 235850 (5.3%) | −183.1 | −181.0 | 0.30 |
| ARID1A SRX5089379 | MCF-7 Breast | 595 / 23585 (2.5%) | 16172 / 235850 (6.9%) | −183.0 | −180.9 | 0.37 |
| FOXA1 SRX3931043 | MCF-7 Breast | 617 / 23585 (2.6%) | 16488 / 235850 (7.0%) | −182.4 | −180.3 | 0.37 |
| EP300 SRX1012648 | MCF-7 Breast | 283 / 23585 (1.2%) | 10979 / 235850 (4.7%) | −182.1 | −180.0 | 0.26 |
| FOXA1 SRX3931054 | MCF-7 Breast | 569 / 23585 (2.4%) | 15728 / 235850 (6.7%) | −182.0 | −180.0 | 0.36 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 560 / 23585 (2.4%) | 15590 / 235850 (6.6%) | −182.0 | −179.9 | 0.36 |
| FOXA1 SRX1447317 | MCF-7 Breast | 392 / 23585 (1.7%) | 12863 / 235850 (5.5%) | −181.9 | −179.8 | 0.30 |
| JUN SRX6582165 | BJ-5ta Epidermis | 1106 / 23585 (4.7%) | 23552 / 235850 (10.0%) | −181.8 | −179.7 | 0.47 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 652 / 23585 (2.8%) | 16974 / 235850 (7.2%) | −181.2 | −179.1 | 0.38 |
| JUNB SRX4192882 | MCF 10A Breast | 480 / 23585 (2.0%) | 14275 / 235850 (6.1%) | −180.8 | −178.7 | 0.34 |
| TEAD1 SRX3401272 | MCF-7 Breast | 460 / 23585 (2.0%) | 13949 / 235850 (5.9%) | −180.7 | −178.7 | 0.33 |
| ESR1 SRX1531796 | MCF-7 Breast | 321 / 23585 (1.4%) | 11607 / 235850 (4.9%) | −180.6 | −178.6 | 0.28 |
| FOXA1 SRX5203303 | MCF-7 Breast | 199 / 23585 (0.8%) | 9354 / 235850 (4.0%) | −180.2 | −178.1 | 0.21 |
| MEN1 SRX11712604 | K-562 Blood | 1820 / 23585 (7.7%) | 8262 / 235850 (3.5%) | −180.1 | −178.0 | 2.20 |
| FOXA1 SRX15430999 | T-47D Breast | 666 / 23585 (2.8%) | 17148 / 235850 (7.3%) | −180.0 | −178.0 | 0.39 |
| YAP1 SRX1038945 | IMR-90 Lung | 454 / 23585 (1.9%) | 13827 / 235850 (5.9%) | −180.0 | −178.0 | 0.33 |
| FOXA1 SRX028635 | MCF-7 Breast | 304 / 23585 (1.3%) | 11292 / 235850 (4.8%) | −180.0 | −177.9 | 0.27 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 935 / 23585 (4.0%) | 2826 / 235850 (1.2%) | −180.0 | −177.9 | 3.31 |
| FOXA1 SRX3923517 | MCF-7 Breast | 431 / 23585 (1.8%) | 13450 / 235850 (5.7%) | −180.0 | −177.9 | 0.32 |
| ESR1 SRX20282959 | MCF-7 Breast | 249 / 23585 (1.1%) | 10293 / 235850 (4.4%) | −179.9 | −177.8 | 0.24 |
| CEBPB SRX2194250 | SUM 159PT Breast | 721 / 23585 (3.1%) | 17967 / 235850 (7.6%) | −179.9 | −177.8 | 0.40 |
| Epitope tags SRX5877914 | U2OS Bone | 3094 / 23585 (13.1%) | 48553 / 235850 (20.6%) | −179.8 | −177.7 | 0.64 |
| ESR1 SRX11120903 | MCF-7 Breast | 522 / 23585 (2.2%) | 14905 / 235850 (6.3%) | −179.5 | −177.5 | 0.35 |
| CDK9 SRX7366783 | MCF-7 Breast | 296 / 23585 (1.3%) | 183 / 235850 (0.1%) | −179.5 | −177.5 | 16.17 |
| NR2F2 SRX190293 | MCF-7 Breast | 641 / 23585 (2.7%) | 16748 / 235850 (7.1%) | −179.5 | −177.4 | 0.38 |
| FOXA1 SRX11222438 | MCF-7 Breast | 326 / 23585 (1.4%) | 11645 / 235850 (4.9%) | −179.1 | −177.1 | 0.28 |
| PGR SRX1012655 | MCF-7 Breast | 391 / 23585 (1.7%) | 12742 / 235850 (5.4%) | −178.7 | −176.6 | 0.31 |
| FOXA1 SRX1787655 | MCF-7 Breast | 309 / 23585 (1.3%) | 11332 / 235850 (4.8%) | −178.6 | −176.6 | 0.27 |
| ESR1 SRX2943589 | MCF-7 Breast | 315 / 23585 (1.3%) | 11438 / 235850 (4.8%) | −178.6 | −176.6 | 0.28 |
| EP300 SRX176885 | MCF-7 Breast | 317 / 23585 (1.3%) | 11468 / 235850 (4.9%) | −178.4 | −176.3 | 0.28 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 838 / 23585 (3.6%) | 19616 / 235850 (8.3%) | −178.1 | −176.1 | 0.43 |
| FOXA1 SRX1787652 | MCF-7 Breast | 378 / 23585 (1.6%) | 12493 / 235850 (5.3%) | −177.8 | −175.8 | 0.30 |
| FOXA1 SRX3931055 | MCF-7 Breast | 523 / 23585 (2.2%) | 14851 / 235850 (6.3%) | −177.7 | −175.7 | 0.35 |
| FOXA1 SRX3923516 | MCF-7 Breast | 441 / 23585 (1.9%) | 13533 / 235850 (5.7%) | −177.6 | −175.6 | 0.33 |
| FOXA1 SRX100506 | Hep G2 Liver | 803 / 23585 (3.4%) | 19087 / 235850 (8.1%) | −177.6 | −175.6 | 0.42 |
| AR SRX1067066 | LHSAR Prostate | 1237 / 23585 (5.2%) | 25169 / 235850 (10.7%) | −177.6 | −175.5 | 0.49 |
| ESR1 SRX3123829 | MCF-7 Breast | 351 / 23585 (1.5%) | 12023 / 235850 (5.1%) | −177.4 | −175.4 | 0.29 |
| ESR1 SRX4451213 | MCF-7 Breast | 616 / 23585 (2.6%) | 16284 / 235850 (6.9%) | −177.3 | −175.3 | 0.38 |
| RUNX1 SRX2513054 | 293 Kidney | 4001 / 23585 (17.0%) | 24767 / 235850 (10.5%) | −177.1 | −175.0 | 1.62 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 785 / 23585 (3.3%) | 18800 / 235850 (8.0%) | −177.1 | −175.0 | 0.42 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 300 / 23585 (1.3%) | 11126 / 235850 (4.7%) | −177.0 | −175.0 | 0.27 |
| FOXA1 SRX3923518 | MCF-7 Breast | 422 / 23585 (1.8%) | 13192 / 235850 (5.6%) | −176.7 | −174.7 | 0.32 |
| NR3C1 SRX2609667 | HASM2 Lung | 598 / 23585 (2.5%) | 15964 / 235850 (6.8%) | −176.2 | −174.1 | 0.37 |
| ESR1 SRX2912055 | MCF-7 Breast | 234 / 23585 (1.0%) | 9898 / 235850 (4.2%) | −176.2 | −174.1 | 0.24 |
| FOXA2 SRX3230382 | Hep G2 Liver | 824 / 23585 (3.5%) | 19331 / 235850 (8.2%) | −176.1 | −174.0 | 0.43 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 575 / 23585 (2.4%) | 15602 / 235850 (6.6%) | −175.9 | −173.9 | 0.37 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 575 / 23585 (2.4%) | 15595 / 235850 (6.6%) | −175.8 | −173.8 | 0.37 |
| JUN SRX2355072 | HAEC Cardiovascular | 787 / 23585 (3.3%) | 18781 / 235850 (8.0%) | −175.8 | −173.7 | 0.42 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 669 / 23585 (2.8%) | 1542 / 235850 (0.7%) | −175.7 | −173.7 | 4.34 |
| IRF3 SRX11453861 | Hep G2 Liver | 263 / 23585 (1.1%) | 124 / 235850 (0.1%) | −175.5 | −173.5 | 21.21 |
| FOXA2 SRX100448 | Hep G2 Liver | 680 / 23585 (2.9%) | 17177 / 235850 (7.3%) | −175.3 | −173.3 | 0.40 |
| JUN SRX6582164 | BJ-5ta Epidermis | 760 / 23585 (3.2%) | 18367 / 235850 (7.8%) | −175.3 | −173.3 | 0.41 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 766 / 23585 (3.2%) | 18451 / 235850 (7.8%) | −175.2 | −173.1 | 0.42 |
| GATA3 SRX6712581 | MCF-7 Breast | 510 / 23585 (2.2%) | 14556 / 235850 (6.2%) | −175.1 | −173.1 | 0.35 |
| AR SRX1067067 | LHSAR Prostate | 1018 / 23585 (4.3%) | 22043 / 235850 (9.3%) | −174.9 | −172.9 | 0.46 |
| ESR1 SRX1012632 | MCF-7 Breast | 307 / 23585 (1.3%) | 11170 / 235850 (4.7%) | −174.7 | −172.7 | 0.27 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2534 / 23585 (10.7%) | 13457 / 235850 (5.7%) | −174.6 | −172.6 | 1.88 |
| NFIC SRX190336 | SK-N-SH Neural | 837 / 23585 (3.5%) | 19459 / 235850 (8.3%) | −174.6 | −172.6 | 0.43 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 435 / 23585 (1.8%) | 13328 / 235850 (5.7%) | −174.4 | −172.4 | 0.33 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 858 / 23585 (3.6%) | 19748 / 235850 (8.4%) | −174.2 | −172.2 | 0.43 |
| STAT5B SRX831881 | CD8+ T cells Blood | 291 / 23585 (1.2%) | 187 / 235850 (0.1%) | −173.9 | −171.9 | 15.56 |
| ESR1 SRX5323873 | MCF-7 Breast | 748 / 23585 (3.2%) | 18131 / 235850 (7.7%) | −173.8 | −171.8 | 0.41 |
| Epitope tags SRX15939725 | RD Muscle | 479 / 23585 (2.0%) | 13989 / 235850 (5.9%) | −173.0 | −171.0 | 0.34 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 450 / 23585 (1.9%) | 13508 / 235850 (5.7%) | −172.6 | −170.6 | 0.33 |
| ESR1 SRX1012633 | MCF-7 Breast | 323 / 23585 (1.4%) | 11373 / 235850 (4.8%) | −172.3 | −170.3 | 0.28 |
| FOXA1 SRX1961157 | T-47D Breast | 670 / 23585 (2.8%) | 16892 / 235850 (7.2%) | −171.8 | −169.8 | 0.40 |
| TP53 SRX19538271 | U2OS Bone | 701 / 23585 (3.0%) | 1728 / 235850 (0.7%) | −171.7 | −169.7 | 4.06 |
| STAT3 SRX2020842 | HCC70 Breast | 1066 / 23585 (4.5%) | 22569 / 235850 (9.6%) | −171.6 | −169.6 | 0.47 |
| FOXA1 SRX3923515 | MCF-7 Breast | 350 / 23585 (1.5%) | 11807 / 235850 (5.0%) | −171.4 | −169.4 | 0.30 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 507 / 23585 (2.1%) | 14373 / 235850 (6.1%) | −171.4 | −169.4 | 0.35 |
| FOXA1 SRX6878603 | LNCAP Prostate | 679 / 23585 (2.9%) | 17015 / 235850 (7.2%) | −171.4 | −169.4 | 0.40 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 238 / 23585 (1.0%) | 9814 / 235850 (4.2%) | −171.0 | −169.0 | 0.24 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 2019 / 23585 (8.6%) | 9842 / 235850 (4.2%) | −170.9 | −168.9 | 2.05 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 421 / 23585 (1.8%) | 12975 / 235850 (5.5%) | −170.9 | −168.9 | 0.32 |
| DPF2 SRX3927297 | MOLM-13 Blood | 718 / 23585 (3.0%) | 17566 / 235850 (7.4%) | −170.6 | −168.6 | 0.41 |
| YAP1 SRX10119364 | MCF 10A Breast | 528 / 23585 (2.2%) | 14676 / 235850 (6.2%) | −170.6 | −168.6 | 0.36 |
| JUNB SRX8488089 | SUM 229PE Breast | 632 / 23585 (2.7%) | 16273 / 235850 (6.9%) | −170.5 | −168.5 | 0.39 |
| NANOG SRX10445309 | Neural crest cells Neural | 341 / 23585 (1.4%) | 11622 / 235850 (4.9%) | −170.5 | −168.5 | 0.29 |
| JUN SRX7277180 | GM07492 Others | 517 / 23585 (2.2%) | 14499 / 235850 (6.1%) | −170.4 | −168.5 | 0.36 |
| MITF SRX7368255 | Hermes 3C Epidermis | 1662 / 23585 (7.0%) | 30455 / 235850 (12.9%) | −170.4 | −168.4 | 0.55 |
| RELA SRX7055007 | HAEC Cardiovascular | 1086 / 23585 (4.6%) | 22775 / 235850 (9.7%) | −169.9 | −168.0 | 0.48 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 464 / 23585 (2.0%) | 13632 / 235850 (5.8%) | −169.8 | −167.8 | 0.34 |
| FOXA1 SRX5323846 | MCF-7 Breast | 239 / 23585 (1.0%) | 9777 / 235850 (4.1%) | −169.3 | −167.3 | 0.24 |
| AR SRX9109110 | MDA-MB-453 Breast | 1133 / 23585 (4.8%) | 23390 / 235850 (9.9%) | −169.2 | −167.2 | 0.48 |
| FOXA1 SRX5323845 | MCF-7 Breast | 236 / 23585 (1.0%) | 9713 / 235850 (4.1%) | −168.9 | −166.9 | 0.24 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 2029 / 23585 (8.6%) | 35012 / 235850 (14.8%) | −168.4 | −166.5 | 0.58 |
| ARID5B SRX3230377 | Hep G2 Liver | 1481 / 23585 (6.3%) | 28001 / 235850 (11.9%) | −168.3 | −166.4 | 0.53 |
| FOXA1 SRX1161205 | T-47D Breast | 340 / 23585 (1.4%) | 11517 / 235850 (4.9%) | −167.8 | −165.9 | 0.30 |
| JUN SRX883584 | MDA-MB-231 Breast | 971 / 23585 (4.1%) | 21082 / 235850 (8.9%) | −167.7 | −165.7 | 0.46 |
| FOXA1 SRX5323829 | T-47D Breast | 358 / 23585 (1.5%) | 11820 / 235850 (5.0%) | −167.7 | −165.7 | 0.30 |
| FOXA1 SRX100477 | Hep G2 Liver | 717 / 23585 (3.0%) | 17431 / 235850 (7.4%) | −167.5 | −165.5 | 0.41 |
| ESR1 SRX2881001 | MCF-7 Breast | 352 / 23585 (1.5%) | 11703 / 235850 (5.0%) | −167.3 | −165.3 | 0.30 |
| FOXA1 SRX1161203 | T-47D Breast | 459 / 23585 (1.9%) | 13468 / 235850 (5.7%) | −167.3 | −165.3 | 0.34 |
| ING2 SRX286201 | RKO Digestive tract | 1777 / 23585 (7.5%) | 8259 / 235850 (3.5%) | −166.9 | −165.0 | 2.15 |
| ESR1 SRX8537723 | MCF-7 Breast | 510 / 23585 (2.2%) | 14264 / 235850 (6.0%) | −166.9 | −164.9 | 0.36 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 427 / 23585 (1.8%) | 12934 / 235850 (5.5%) | −166.9 | −164.9 | 0.33 |
| CEBPB SRX190345 | MCF-7 Breast | 491 / 23585 (2.1%) | 13950 / 235850 (5.9%) | −166.6 | −164.6 | 0.35 |
| ESR1 SRX3110723 | MCF-7 Breast | 350 / 23585 (1.5%) | 11647 / 235850 (4.9%) | −166.5 | −164.6 | 0.30 |
| MLXIP SRX5391034 | Skeletal myotubes Muscle | 764 / 23585 (3.2%) | 18075 / 235850 (7.7%) | −166.4 | −164.5 | 0.42 |
| ESR1 SRX1469951 | MCF-7 Breast | 336 / 23585 (1.4%) | 11406 / 235850 (4.8%) | −166.4 | −164.5 | 0.29 |
| ESR1 SRX2513517 | MCF-7 Breast | 433 / 23585 (1.8%) | 13014 / 235850 (5.5%) | −166.4 | −164.4 | 0.33 |
| FOXA1 SRX3923519 | MCF-7 Breast | 394 / 23585 (1.7%) | 12376 / 235850 (5.2%) | −166.3 | −164.4 | 0.32 |
| CEBPA SRX2630241 | Hep G2 Liver | 768 / 23585 (3.3%) | 18130 / 235850 (7.7%) | −166.3 | −164.3 | 0.42 |
| CDK9 SRX7366781 | MCF-7 Breast | 276 / 23585 (1.2%) | 174 / 235850 (0.1%) | −166.2 | −164.2 | 15.86 |
| ESR1 SRX1012630 | MCF-7 Breast | 248 / 23585 (1.1%) | 9849 / 235850 (4.2%) | −166.2 | −164.2 | 0.25 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 1066 / 23585 (4.5%) | 22336 / 235850 (9.5%) | −166.1 | −164.1 | 0.48 |
| EP300 SRX150579 | HeLa Uterus | 426 / 23585 (1.8%) | 12887 / 235850 (5.5%) | −165.9 | −164.0 | 0.33 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 367 / 23585 (1.6%) | 11909 / 235850 (5.0%) | −165.9 | −163.9 | 0.31 |
| CEBPB SRX150598 | IMR-90 Lung | 1225 / 23585 (5.2%) | 24470 / 235850 (10.4%) | −165.4 | −163.5 | 0.50 |
| FOXA1 SRX3931033 | MCF-7 Breast | 412 / 23585 (1.7%) | 12636 / 235850 (5.4%) | −165.3 | −163.4 | 0.33 |
| JUNB SRX10119383 | MCF 10A Breast | 448 / 23585 (1.9%) | 13216 / 235850 (5.6%) | −165.3 | −163.3 | 0.34 |
| FOXA1 SRX1961158 | T-47D Breast | 629 / 23585 (2.7%) | 16026 / 235850 (6.8%) | −165.1 | −163.2 | 0.39 |
| SSRP1 SRX3436566 | HT-1080 Bone | 381 / 23585 (1.6%) | 469 / 235850 (0.2%) | −164.7 | −162.8 | 8.12 |
| NFYB SRX16608147 | HeLa Uterus | 308 / 23585 (1.3%) | 258 / 235850 (0.1%) | −164.1 | −162.2 | 11.94 |
| ESR1 SRX2513520 | MCF-7 Breast | 403 / 23585 (1.7%) | 12444 / 235850 (5.3%) | −164.0 | −162.1 | 0.32 |
| NR3C1 SRX2609668 | HASM2 Lung | 491 / 23585 (2.1%) | 13849 / 235850 (5.9%) | −163.8 | −161.9 | 0.35 |
| STAT3 SRX150479 | MCF 10A Breast | 593 / 23585 (2.5%) | 15425 / 235850 (6.5%) | −163.7 | −161.8 | 0.38 |
| ESR1 SRX5323878 | MCF-7 Breast | 637 / 23585 (2.7%) | 16086 / 235850 (6.8%) | −163.5 | −161.5 | 0.40 |
| OLIG2 SRX22544825 | Glioma Neural | 634 / 23585 (2.7%) | 16023 / 235850 (6.8%) | −163.1 | −161.1 | 0.40 |
| FOXA1 SRX5203294 | MCF-7 Breast | 189 / 23585 (0.8%) | 8643 / 235850 (3.7%) | −162.9 | −160.9 | 0.22 |
| ESR1 SRX5323871 | MCF-7 Breast | 695 / 23585 (2.9%) | 16915 / 235850 (7.2%) | −162.6 | −160.7 | 0.41 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 427 / 23585 (1.8%) | 12780 / 235850 (5.4%) | −162.4 | −160.5 | 0.33 |
| NR3C1 SRX19024866 | MCF-7 Breast | 233 / 23585 (1.0%) | 9456 / 235850 (4.0%) | −162.3 | −160.4 | 0.25 |
| SOX13 SRX2636248 | Hep G2 Liver | 864 / 23585 (3.7%) | 19352 / 235850 (8.2%) | −162.3 | −160.4 | 0.45 |
| FOXA1 SRX5203307 | MCF-7 Breast | 196 / 23585 (0.8%) | 8759 / 235850 (3.7%) | −162.2 | −160.3 | 0.22 |
| FOXA1 SRX1447316 | MCF-7 Breast | 278 / 23585 (1.2%) | 10256 / 235850 (4.3%) | −162.1 | −160.2 | 0.27 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 236 / 23585 (1.0%) | 9500 / 235850 (4.0%) | −162.0 | −160.1 | 0.25 |
| ESR1 SRX1995229 | MCF-7 Breast | 631 / 23585 (2.7%) | 15933 / 235850 (6.8%) | −161.9 | −160.0 | 0.40 |
| MLLT6 DRX059637 | 293 Kidney | 479 / 23585 (2.0%) | 836 / 235850 (0.4%) | −161.8 | −159.8 | 5.73 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 551 / 23585 (2.3%) | 14707 / 235850 (6.2%) | −161.6 | −159.6 | 0.37 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 535 / 23585 (2.3%) | 14455 / 235850 (6.1%) | −161.5 | −159.6 | 0.37 |
| EP300 SRX1012644 | MCF-7 Breast | 300 / 23585 (1.3%) | 10619 / 235850 (4.5%) | −161.3 | −159.4 | 0.28 |
| FOXL2 SRX6957477 | KGN Gonad | 666 / 23585 (2.8%) | 16436 / 235850 (7.0%) | −161.3 | −159.4 | 0.41 |
| ESR1 SRX3110720 | MCF-7 Breast | 271 / 23585 (1.1%) | 10102 / 235850 (4.3%) | −161.2 | −159.3 | 0.27 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 2003 / 23585 (8.5%) | 9977 / 235850 (4.2%) | −160.9 | −158.9 | 2.01 |
| EP300 SRX190219 | SK-N-SH Neural | 625 / 23585 (2.6%) | 15802 / 235850 (6.7%) | −160.8 | −158.9 | 0.40 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 747 / 23585 (3.2%) | 17595 / 235850 (7.5%) | −160.6 | −158.6 | 0.42 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 245 / 23585 (1.0%) | 9614 / 235850 (4.1%) | −160.5 | −158.6 | 0.25 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1375 / 23585 (5.8%) | 5729 / 235850 (2.4%) | −160.4 | −158.4 | 2.40 |
| ESR1 SRX4451212 | MCF-7 Breast | 613 / 23585 (2.6%) | 15602 / 235850 (6.6%) | −160.3 | −158.4 | 0.39 |
| ESR1 SRX5323872 | MCF-7 Breast | 643 / 23585 (2.7%) | 16050 / 235850 (6.8%) | −160.2 | −158.3 | 0.40 |
| JUNB SRX10119384 | MCF 10A Breast | 406 / 23585 (1.7%) | 12361 / 235850 (5.2%) | −160.2 | −158.2 | 0.33 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 555 / 23585 (2.4%) | 14709 / 235850 (6.2%) | −160.1 | −158.2 | 0.38 |
| FOXA1 SRX3923511 | MCF-7 Breast | 254 / 23585 (1.1%) | 9762 / 235850 (4.1%) | −160.0 | −158.1 | 0.26 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 193 / 23585 (0.8%) | 8631 / 235850 (3.7%) | −160.0 | −158.1 | 0.22 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 556 / 23585 (2.4%) | 14711 / 235850 (6.2%) | −159.7 | −157.8 | 0.38 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 187 / 23585 (0.8%) | 8505 / 235850 (3.6%) | −159.6 | −157.7 | 0.22 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 558 / 23585 (2.4%) | 14716 / 235850 (6.2%) | −158.9 | −157.0 | 0.38 |
| GFP SRX6949256 | HeLa Uterus | 701 / 23585 (3.0%) | 16860 / 235850 (7.1%) | −158.9 | −157.0 | 0.42 |
| FOS SRX070879 | HUVEC Cardiovascular | 684 / 23585 (2.9%) | 16604 / 235850 (7.0%) | −158.8 | −156.9 | 0.41 |
| STAT3 SRX150630 | MCF 10A Breast | 600 / 23585 (2.5%) | 15347 / 235850 (6.5%) | −158.7 | −156.8 | 0.39 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 982 / 23585 (4.2%) | 20853 / 235850 (8.8%) | −158.6 | −156.7 | 0.47 |
| FOXO1 SRX1048948 | Endometrial stromal cells Uterus | 330 / 23585 (1.4%) | 11042 / 235850 (4.7%) | −158.5 | −156.6 | 0.30 |
| Epitope tags SRX10549777 | K-562 Blood | 3091 / 23585 (13.1%) | 18197 / 235850 (7.7%) | −158.5 | −156.6 | 1.70 |
| ESR1 SRX330068 | MCF-7 Breast | 321 / 23585 (1.4%) | 10883 / 235850 (4.6%) | −158.4 | −156.5 | 0.29 |
| ESR1 SRX10365534 | MCF-7 Breast | 205 / 23585 (0.9%) | 8807 / 235850 (3.7%) | −158.3 | −156.4 | 0.23 |
| ESR1 SRX1012625 | MCF-7 Breast | 351 / 23585 (1.5%) | 11383 / 235850 (4.8%) | −158.2 | −156.3 | 0.31 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 858 / 23585 (3.6%) | 19093 / 235850 (8.1%) | −158.1 | −156.2 | 0.45 |
| 5-mC SRX882965 | LNCAP Prostate | 2861 / 23585 (12.1%) | 16423 / 235850 (7.0%) | −158.1 | −156.2 | 1.74 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 827 / 23585 (3.5%) | 18628 / 235850 (7.9%) | −157.5 | −155.7 | 0.44 |
| MITF SRX7368256 | Hermes 3C Epidermis | 1204 / 23585 (5.1%) | 23807 / 235850 (10.1%) | −156.8 | −154.9 | 0.51 |
| LARP7 SRX2198835 | HeLa Uterus | 2649 / 23585 (11.2%) | 14846 / 235850 (6.3%) | −156.7 | −154.8 | 1.78 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 584 / 23585 (2.5%) | 15025 / 235850 (6.4%) | −156.6 | −154.8 | 0.39 |
| ESR1 SRX2513521 | MCF-7 Breast | 322 / 23585 (1.4%) | 10836 / 235850 (4.6%) | −156.4 | −154.6 | 0.30 |
| EP300 SRX1012643 | MCF-7 Breast | 250 / 23585 (1.1%) | 9570 / 235850 (4.1%) | −156.2 | −154.3 | 0.26 |
| GATA2 SRX7767648 | Endometrial stromal cells Uterus | 223 / 23585 (0.9%) | 9071 / 235850 (3.8%) | −156.1 | −154.2 | 0.25 |
| ARID1A SRX5089385 | MCF-7 Breast | 503 / 23585 (2.1%) | 13757 / 235850 (5.8%) | −156.0 | −154.1 | 0.37 |
| FOXA1 SRX5323830 | T-47D Breast | 402 / 23585 (1.7%) | 12148 / 235850 (5.2%) | −155.9 | −154.0 | 0.33 |
| TLE3 SRX4815194 | SUM 149PT Breast | 508 / 23585 (2.2%) | 13827 / 235850 (5.9%) | −155.9 | −154.0 | 0.37 |
| FOXA1 SRX5323844 | MCF-7 Breast | 195 / 23585 (0.8%) | 8533 / 235850 (3.6%) | −155.4 | −153.6 | 0.23 |
| EP300 SRX176883 | MCF-7 Breast | 321 / 23585 (1.4%) | 10782 / 235850 (4.6%) | −155.4 | −153.5 | 0.30 |
| ESR1 SRX20282966 | MCF-7 Breast | 245 / 23585 (1.0%) | 9452 / 235850 (4.0%) | −155.3 | −153.4 | 0.26 |
| ZEB1 SRX13298925 | MCF-7 Breast | 419 / 23585 (1.8%) | 12400 / 235850 (5.3%) | −155.3 | −153.4 | 0.34 |
| GATAD2A SRX2636506 | Hep G2 Liver | 830 / 23585 (3.5%) | 18574 / 235850 (7.9%) | −155.2 | −153.3 | 0.45 |
| RBM22 SRX4708083 | K-562 Blood | 1136 / 23585 (4.8%) | 4330 / 235850 (1.8%) | −154.9 | −153.1 | 2.62 |
| JUND SRX699738 | HCASMC Cardiovascular | 889 / 23585 (3.8%) | 19396 / 235850 (8.2%) | −154.9 | −153.0 | 0.46 |
| PAF1 SRX15147186 | DLD-1 Digestive tract | 977 / 23585 (4.1%) | 3388 / 235850 (1.4%) | −154.8 | −153.0 | 2.88 |
| OLIG2 SRX22544827 | Glioma Neural | 888 / 23585 (3.8%) | 19377 / 235850 (8.2%) | −154.8 | −152.9 | 0.46 |
| ESR1 SRX5323877 | MCF-7 Breast | 521 / 23585 (2.2%) | 13987 / 235850 (5.9%) | −154.6 | −152.7 | 0.37 |
| ESR1 SRX1995230 | MCF-7 Breast | 553 / 23585 (2.3%) | 14469 / 235850 (6.1%) | −154.4 | −152.6 | 0.38 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 936 / 23585 (4.0%) | 20037 / 235850 (8.5%) | −154.4 | −152.6 | 0.47 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 502 / 23585 (2.1%) | 13683 / 235850 (5.8%) | −154.4 | −152.6 | 0.37 |
| TCF21 DRX190656 | HCF Cardiovascular | 851 / 23585 (3.6%) | 18840 / 235850 (8.0%) | −154.4 | −152.5 | 0.45 |
| PROX1 SRX3230397 | Hep G2 Liver | 490 / 23585 (2.1%) | 13485 / 235850 (5.7%) | −154.2 | −152.3 | 0.36 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 223 / 23585 (0.9%) | 9007 / 235850 (3.8%) | −154.0 | −152.1 | 0.25 |
| ESR1 SRX4451214 | MCF-7 Breast | 579 / 23585 (2.5%) | 14837 / 235850 (6.3%) | −153.7 | −151.8 | 0.39 |
| MYC SRX13134693 | 293 Kidney | 1621 / 23585 (6.9%) | 7488 / 235850 (3.2%) | −153.7 | −151.8 | 2.16 |
| NCOA3 SRX4663589 | MCF-7 Breast | 197 / 23585 (0.8%) | 8516 / 235850 (3.6%) | −153.6 | −151.8 | 0.23 |
| STAT3 SRX150536 | MCF 10A Breast | 728 / 23585 (3.1%) | 17040 / 235850 (7.2%) | −153.5 | −151.6 | 0.43 |
| FOXA1 SRX3931032 | MCF-7 Breast | 397 / 23585 (1.7%) | 11970 / 235850 (5.1%) | −153.2 | −151.3 | 0.33 |
| CEBPB SRX2194249 | SUM 159PT Breast | 643 / 23585 (2.7%) | 15777 / 235850 (6.7%) | −153.1 | −151.3 | 0.41 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 859 / 23585 (3.6%) | 18895 / 235850 (8.0%) | −153.0 | −151.2 | 0.45 |
| FOXA1 SRX6878604 | LNCAP Prostate | 537 / 23585 (2.3%) | 14170 / 235850 (6.0%) | −152.9 | −151.1 | 0.38 |
| ESR1 SRX1012631 | MCF-7 Breast | 304 / 23585 (1.3%) | 10408 / 235850 (4.4%) | −152.9 | −151.1 | 0.29 |
| ATF1 SRX11470442 | Mesenchymal stem cells Others | 825 / 23585 (3.5%) | 18404 / 235850 (7.8%) | −152.8 | −150.9 | 0.45 |
| FOXA1 SRX1161207 | T-47D Breast | 287 / 23585 (1.2%) | 10104 / 235850 (4.3%) | −152.6 | −150.8 | 0.28 |
| RUNX1 SRX10119135 | MV-4-11 Blood | 706 / 23585 (3.0%) | 16680 / 235850 (7.1%) | −152.5 | −150.6 | 0.42 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 785 / 23585 (3.3%) | 2354 / 235850 (1.0%) | −152.4 | −150.6 | 3.33 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 472 / 23585 (2.0%) | 13139 / 235850 (5.6%) | −152.3 | −150.5 | 0.36 |
| FOXA1 SRX190181 | A549 Lung | 491 / 23585 (2.1%) | 13437 / 235850 (5.7%) | −152.3 | −150.5 | 0.37 |
| FOS SRX150664 | HUVEC Cardiovascular | 854 / 23585 (3.6%) | 18795 / 235850 (8.0%) | −152.3 | −150.4 | 0.45 |
| Epitope tags SRX5877913 | U2OS Bone | 3164 / 23585 (13.4%) | 47820 / 235850 (20.3%) | −152.3 | −150.4 | 0.66 |
| AR SRX9109113 | MDA-MB-453 Breast | 1202 / 23585 (5.1%) | 23560 / 235850 (10.0%) | −152.1 | −150.2 | 0.51 |
| ESR1 SRX2513518 | MCF-7 Breast | 335 / 23585 (1.4%) | 10908 / 235850 (4.6%) | −152.0 | −150.2 | 0.31 |
| NR3C1 SRX19024870 | MCF-7 Breast | 238 / 23585 (1.0%) | 9214 / 235850 (3.9%) | −151.9 | −150.0 | 0.26 |
| ESR1 SRX5534832 | MCF-7 Breast | 606 / 23585 (2.6%) | 15168 / 235850 (6.4%) | −151.7 | −149.8 | 0.40 |
| NANOG SRX702040 | hESC HUES64 Pluripotent stem cell | 145 / 23585 (0.6%) | 7438 / 235850 (3.2%) | −151.6 | −149.7 | 0.19 |
| ESR1 SRX792933 | LY2 Breast | 555 / 23585 (2.4%) | 14364 / 235850 (6.1%) | −150.8 | −149.0 | 0.39 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 1502 / 23585 (6.4%) | 6750 / 235850 (2.9%) | −150.8 | −149.0 | 2.23 |
| ZEB1 SRX13298923 | MCF-7 Breast | 295 / 23585 (1.3%) | 10177 / 235850 (4.3%) | −150.6 | −148.8 | 0.29 |
| FOS SRX3322636 | MCF-7 Breast | 454 / 23585 (1.9%) | 12790 / 235850 (5.4%) | −150.6 | −148.7 | 0.35 |
| TFAP2C SRX018833 | MCF-7 Breast | 610 / 23585 (2.6%) | 15181 / 235850 (6.4%) | −150.5 | −148.7 | 0.40 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 203 / 23585 (0.9%) | 8532 / 235850 (3.6%) | −150.5 | −148.7 | 0.24 |
| JUND SRX150408 | HeLa Uterus | 600 / 23585 (2.5%) | 15031 / 235850 (6.4%) | −150.5 | −148.6 | 0.40 |
| CEBPA SRX097095 | U-937 Blood | 518 / 23585 (2.2%) | 13771 / 235850 (5.8%) | −150.1 | −148.3 | 0.38 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1619 / 23585 (6.9%) | 7555 / 235850 (3.2%) | −150.1 | −148.3 | 2.14 |
| WWTR1 SRX10119378 | MCF 10A Breast | 721 / 23585 (3.1%) | 16789 / 235850 (7.1%) | −149.8 | −148.0 | 0.43 |
| AR SRX15946405 | MDA-MB-453 Breast | 435 / 23585 (1.8%) | 12461 / 235850 (5.3%) | −149.7 | −147.9 | 0.35 |
| FOXA1 SRX3931056 | MCF-7 Breast | 411 / 23585 (1.7%) | 12069 / 235850 (5.1%) | −149.5 | −147.7 | 0.34 |
| AR SRX11149848 | MDA-MB-453 Breast | 436 / 23585 (1.8%) | 12462 / 235850 (5.3%) | −149.3 | −147.5 | 0.35 |
| ARID5B SRX10475139 | Hep G2 Liver | 727 / 23585 (3.1%) | 16844 / 235850 (7.1%) | −149.0 | −147.2 | 0.43 |
| TFAP2C SRX128099 | MCF-7 Breast | 613 / 23585 (2.6%) | 15167 / 235850 (6.4%) | −148.9 | −147.1 | 0.40 |
| ARID1A SRX5089382 | MCF-7 Breast | 491 / 23585 (2.1%) | 13307 / 235850 (5.6%) | −148.9 | −147.0 | 0.37 |
| BRD4 SRX3031983 | MV-4-11 Blood | 876 / 23585 (3.7%) | 18960 / 235850 (8.0%) | −148.8 | −147.0 | 0.46 |
| ESR1 SRX2513519 | MCF-7 Breast | 379 / 23585 (1.6%) | 11521 / 235850 (4.9%) | −148.8 | −146.9 | 0.33 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 448 / 23585 (1.9%) | 12631 / 235850 (5.4%) | −148.8 | −146.9 | 0.35 |
| ESR1 SRX1012628 | MCF-7 Breast | 358 / 23585 (1.5%) | 11179 / 235850 (4.7%) | −148.7 | −146.9 | 0.32 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 851 / 23585 (3.6%) | 18602 / 235850 (7.9%) | −148.7 | −146.9 | 0.46 |
| ESR1 SRX5534831 | MCF-7 Breast | 531 / 23585 (2.3%) | 13917 / 235850 (5.9%) | −148.7 | −146.9 | 0.38 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 1128 / 23585 (4.8%) | 22407 / 235850 (9.5%) | −148.5 | −146.7 | 0.50 |
Showing first 500 of 21274 rows.